ecancer

3 or 6 months adjuvant oxaliplatin for colorectal cancer

Dr Tim Iveson - University Hospital Southampton, Salisbury, UK

4 Jun 2017

Discovering genes in mammary cancer by insertional mutagenesis

Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands

27 Apr 2017

Final results of the HERACLES trial in HER2-amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy

10 Apr 2017

Treatment choices for HER2 amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy

10 Apr 2017

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA

10 Apr 2017

Neratinib in HER2 or HER3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA

10 Apr 2017

Boosted radiotherapy fractions to treat rectal cancer

Dr Krzysztof Bujko - Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland

$Boosted radiotherapy fractions to treat rectal cancer ( Dr Krzysztof Bujko - Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland )$

29 Mar 2017

Editor's Choice for March 2017

Prof Gordon McVie - Editor in Chief, ecancer

23 Mar 2017

Treatment of gastric cancer in Latin America

Dr Christian Caglevic - Arturo López Pérez Foundation, FALP, Santiago, Chile

6 Jan 2017

Standardised tobacco packaging in the UK

Prof Ann McNeill - King's College London, London, UK

5 Jan 2017

Immunotherapy for gastric cancer

Prof Yung-Jue Bang - Seoul National University College of Medicine, South Korea

3 Jan 2017

Personalised therapy for gastric and pancreatic cancer

Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany

21 Dec 2016

More from ecancer